Article Information
History
- September 20, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Anne Mehnert1,
- Sivan Bershan2,
- Jil Kollmus-Heege3,
- Lea Gerischer1,4,
- Meret Luise Herdick1,4,
- Sarah Hoffmann1,4,
- Sophie Lehnerer1,4,5,
- Franziska Scheibe1,
- Frauke Stascheit1,4,
- Maike Stein1,4,
- Alastair M. Buchan2,6,
- Andreas Meisel1,2,4,
- Annette Aigner2,3,* and
- Philipp Mergenthaler1,2,6,*,#
- 1Charité – Universitätsmedizin Berlin, Dept. of Neurology with Experimental Neurology, Berlin, Germany
- 2Charité – Universitätsmedizin Berlin, Center for Stroke Research Berlin, Berlin, Germany
- 3Charité – Universitätsmedizin Berlin, Institute of Biometry and Clinical Epidemiology, Berlin, Germany
- 4Charité – Universitätsmedizin Berlin, Neuroscience Clinical Research Center, Berlin, Germany
- 5Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Digital Health Center, Berlin, Germany
- 6Radcliffe Department of Medicine, University of Oxford, Oxford, UK
- ↵#Correspondence: Philipp Mergenthaler, Charité – Universitätsmedizin Berlin, Center for Stroke Research Berlin, Charitéplatz 1, 10117 Berlin, Germany, Email: philipp.mergenthaler{at}charite.de, Tel: +49 30 450 560 020.
↵* equal contribution
Posted September 20, 2023.
Identifying patients at risk for myasthenic crisis with hemogram and inflammation-related laboratory parameters – a pilot study
